Organovo Holdings 株価情報 (NASDAQ: ONVO)

Organovo Holdings (NASDAQ:ONVO) 株価情報

Organovo Holdings

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Organovo Holdings Inc

<h3>Gainers</h3>
<ul>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) shares rose 86.6% to $9.52 during Friday's regular session. The market value of their outstanding shares is at $15.6 million. </li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSPR#NASDAQ">MSPR</a>) stock moved upwards by 85.15% to $2.37. The company's market cap stands at $5.0 million. </li>
<li>CeriBell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLL#NASDAQ">CBLL</a>) shares rose 35.78% to $15.14. The company's market cap stands at $543.0 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares increased by 35.02% to $38.13. The company's market cap stands at $496.1 million. </li>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares moved upwards by 34.42% to $0.02. </li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) shares rose 27.88% to $0.27. The company's market cap stands at $22.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) stock fell 53.3% to $2.31 during Friday's regular session. The company's market cap stands at $5.6 million. </li>
<li>Palatin Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PTN#AMEX">PTN</a>) stock declined by 44.04% to $0.24. The market value of their outstanding shares is at $6.1 million. </li>
<li>Wellgistics Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGRX#NASDAQ">WGRX</a>) shares declined by 29.45% to $2.76. The market value of their outstanding shares is at $143.2 million. </li>
<li>Organovo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) stock fell 22.96% to $1.68. The market value of their outstanding shares is at $3.0 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock declined by 21.52% to $0.22. The company's market cap stands at $1.3 million. </li>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) shares declined by 15.96% to $0.48. The market value of their outstanding shares is at $5.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CBLL

LUCY

MSPR

ONVO

PRTG

RSLS

STSS

WGRX

YCBD

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSPR#NASDAQ">MSPR</a>) shares increased by 124.2% to $2.87 during Friday's pre-market session. The company's market cap stands at $6.0 million. </li>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) stock increased by 31.69% to $0.02. </li>
<li>Simulations Plus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) shares moved upwards by 22.17% to $31.45. The company's market cap stands at $632.4 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) stock rose 20.43% to $7.77. The company's market cap stands at $5.8 million. </li>
<li>Certara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) stock moved upwards by 18.36% to $12.44. The market value of their outstanding shares is at $2.0 billion. </li>
<li>Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) stock moved upwards by 17.74% to $2.19. The market value of their outstanding shares is at $162.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Performant Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHLT#NASDAQ">PHLT</a>) shares declined by 38.0% to $1.5 during Friday's pre-market session. The company's market cap stands at $117.4 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock decreased by 35.26% to $0.18. The market value of their outstanding shares is at $1.1 million. </li>
<li>Palatin Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PTN#AMEX">PTN</a>) stock decreased by 31.64% to $0.29. The company's market cap stands at $7.5 million. </li>
<li>KORU Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRMD#NASDAQ">KRMD</a>) shares fell 29.39% to $1.61. The market value of their outstanding shares is at $74.2 million. </li>
<li>Organovo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) stock declined by 24.78% to $1.64. The market value of their outstanding shares is at $2.9 million. </li>
<li>Mesoblast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) stock declined by 23.08% to $8.0. The market value of their outstanding shares is at $1.0 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CATX

CERT

KRMD

MESO

NAOV

PHLT

12 Health Care Stocks Moving In Friday's Pre-Market Session

Shares of argenx SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) rose sharply in today's pre-market trading after the company announced the FDA approval of VYVGART Hytrulo prefilled syringe for self-injection in generalized myasthenia gravis and <a href="https://www.benzinga.com/quote/ARGX">chronic inflammatory demyelinating polyneuropathy.</a>
argenx shares jumped 5.1% to $573.88 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>MSP Recovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSPR#NASDAQ">MSPR</a>) rose 167% to $3.43 in pre-market trading as the company announced strategic term sheet providing prospective liquidity and restructuring of existing agreements to remove corporate guaranteed debt by over $1.2 billion as well as new agreements aimed at driving future growth.</li>
<li>Sharps Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) surged 73.6% to $0.0318 in pre-market trading after jumping 30% on Thursday.</li>
<li>Enzo Biochem, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENZ#NYSE">ENZ</a>) gained 26.5% to $0.3300 in pre-market after dipping 22% on Thursday.</li>
<li>Actelis Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) rose 26.4% to $0.8198 in pre-market trading. Actelis Networks recently announced it received a new order to modernize Orange County&#8217;s traffic infrastructure.</li>
<li>Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) rose 25.6% to $5.10 in pre-market trading. Venus Concept announced closing of $1.1 million registered direct offering of common stock priced at-the-market under Nasdaq rules.</li>
<li>DMC Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) gained 21.7% to $7.90 in pre-market trading.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) jumped 19.1% to $5.37 in pre-market trading.</li>
<li>Certara, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) surged 18.1% to $12.41 in pre-market trading after gaining 8% on Thursday.</li>
<li>Simulations Plus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) gained 13.7% to $29.23 in pre-market trading. The stock may be moving up after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>AlTi Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) fell 57.3% to $1.20 in pre-market trading after declining around 6% on Thursday.</li>
<li>cbdMD, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#NYSE">YCBD</a>) shares tumbled 38.9% to $0.1701 in pre-market trading. CbdMD announced shareholder approval of automatic conversion of series a preferred stock and other results from annual meeting.</li>
<li>Nexa Resources S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEXA#NYSE">NEXA</a>) fell 32% to $4.01 in today's pre-market trading.</li>
<li>Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) shares fell 27.1% to $1.59 in pre-market trading.</li>
<li>Palatin Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PTN#NYSE">PTN</a>) fell 16.8% to $0.3510 in pre-market trading after the company announced it received a NYSE American notice of delisting.</li>
<li>Betterware de México, S.A.P.I. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWMX#NYSE">BWMX</a>) shares fell 24% to $8.21 in pre-market trading. Betterware de México will report its first quarter results after the U.S. market close on Thursday, April 24.</li>
<li>Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) shares dipped 22.3% to $2.20 in pre-market trading.</li>
<li>InnovAge Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) fell 14.9% to $2.35 in pre-market trading.</li>
<li>Costamare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMRE#NYSE">CMRE</a>) dipped 14.3% to $7.42 in pre-market trading after falling 5% on Thursday.</li>
<li>Maze Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>) declined 12.8% to $6.62 in pre-market trading after falling 5% on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44734419/top-2-real-estate-stocks-that-may-keep-you-up-at-night-this-month">Top 2 Real Estate Stocks That May Keep You Up At Night This Month</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

ALTI

ARGX

ASNS

BOOM

BWMX

CMRE

INNV

MAZE

NEXA

RXRX

SLSR

VERO

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) shares moved upwards by 36.7% to $5.55 during Thursday's after-market session. The company's market cap stands at $3.6 million. </li>
<li>Creative Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELZ#NASDAQ">CELZ</a>) shares moved upwards by 31.03% to $2.36. The company's market cap stands at $5.9 million. </li>
<li>Organovo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) shares rose 30.27% to $2.84. The company's market cap stands at $5.1 million. </li>
<li>Certara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) stock moved upwards by 26.67% to $13.44. The company's market cap stands at $2.1 billion. </li>
<li>Simulations Plus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) stock moved upwards by 24.7% to $32.1. The company's market cap stands at $645.5 million. </li>
<li>Recursion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) stock rose 20.61% to $5.44. The company's market cap stands at $2.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) stock fell 27.0% to $1.03 during Thursday's after-market session. The company's market cap stands at $34.7 million. </li>
<li>Palatin Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PTN#AMEX">PTN</a>) shares fell 26.34% to $0.31. The company's market cap stands at $8.0 million. </li>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) stock fell 13.77% to $4.29. The market value of their outstanding shares is at $10.5 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares fell 13.29% to $0.38. The market value of their outstanding shares is at $2.0 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) shares declined by 10.86% to $5.75. The market value of their outstanding shares is at $4.3 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares declined by 9.72% to $0.25. The market value of their outstanding shares is at $1.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CELZ

NIVF

NOTV

12 Health Care Stocks Moving In Thursday's After-Market Session

News

Organovo Holdings Expects To Meet Nasdaq Continued Listing Requirements

Guidance

Organovo Holdings Sees Prelim Q4 Cash And Cash Equivalents ~$11.3M

Biotech

General

Organovo Says with The Closing Of The Sale Of Its FXR Program To Lilly, It Has Received Upfront Payments And Anticipates Future Milestone Payments

<a href="https://patentcenter.uspto.gov/applications/17695538/ifw/docs">https://patentcenter.uspto.gov/applications/17695538/ifw/docs</a>
<figure class="image"><img src="https://pbs.twimg.com/media/GmksvBoawAAzgIx?format=jpg&amp;name=small" alt="Image" /></figure>
<img src="https://pbs.twimg.com/media/GmksvA7aUAA2WeT?format=jpg&amp;name=small" alt="Image" />

Organovo Has Received A Notice Of Allowance For A U.S. Patent Titled "Engineered Intestinal Tissue And Uses Thereof"

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 200 points on Wednesday.
The Dow traded up 0.55% to 41,808.59 while the NASDAQ climbed 0.95% to 17,671.26. The S&amp;P 500 also rose, gaining, 0.66% to 5,651.61.
Check This Out: <a href="https://www.benzinga.com/25/03/44396179/how-to-earn-500-a-month-from-jabil-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Jabil Stock Ahead Of Q2 Earnings</a>
Leading and Lagging Sectors Energy shares rose by 1.2% on Wednesday.
In trading on Wednesday, real estate shares fell by 0.7%.
Top Headline
The EIA said crude oil inventories in the US increased by 1.745 million barrels in the week ended March 14, compared to market estimates of a 1.1 million gain.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Service Properties Trust &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVC#NASDAQ">SVC</a>) shares shot up 18% to $2.94 after Wells Fargo upgraded the stock from Underweight to Overweight and raised its price target from $2.5 to $4.</li>
<li>Shares of Aterian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>)got a boost, surging 31% to $2.7640 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>BGM Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGM#NASDAQ">BGM</a>) shares were also up, gaining 16% to $11.79 after the company announced the acquisition of YX for $95 million.</li>
</ul>
Equities Trading DOWN
<ul>
<li>HealthEquity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) shares dropped 18% to $83.35 after the company reported worse-than-expected fourth-quarter adjusted EPS results.</li>
<li>Shares of Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) were down 30% to $0.2815 after the company announced a 1-for-12 reverse stock split.</li>
<li>OmniAb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OABI#NASDAQ">OABI</a>) was down, falling 17% to $2.6545 following fourth-quarter earnings.</li>
</ul>
Commodities In commodity news, oil traded up 0.7% to $67.38 while gold traded down 0.1% at $3,040.50.
Silver traded down 1.6% to $34.275 on Wednesday, while copper rose 1.2% to $5.0765.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.12%, Germany's DAX 40 fell 0.55% and France's CAC 40 gained 0.65%. Spain's IBEX 35 Index rose 0.30%, while London's FTSE 100 rose 0.08%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.25%, China's Shanghai Composite Index falling 0.1%, Hong Kong's Hang Seng Index gaining 0.12% and India's BSE Sensex gaining 0.20%.
Economics
<ul>
<li>U.S. mortgage applications declined by 6.2% in the second week of March, following a cumulative 37% increase from the two prior weeks.</li>
<li>The EIA said crude oil inventories in the US increased by 1.745 million barrels in the week ended March 14, compared to market estimates of a 1.1 million gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks">Jim Cramer Says TJX Is &#8216;Terrific,&#8217; Recommends Buying These Stocks</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

ATER

OABI

Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 1% on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.56% to 41,814.36 while the NASDAQ climbed 1.16% to 17,706.90. The S&amp;P 500 also rose, gaining, 0.78% to 5,658.21.
Check This Out: <a href="https://www.benzinga.com/25/03/44396179/how-to-earn-500-a-month-from-jabil-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Jabil Stock Ahead Of Q2 Earnings</a>
Leading and Lagging Sectors Information technology shares rose by 1.5% on Wednesday.
In trading on Wednesday, real estate shares fell by 0.2%.
Top Headline
Shares of Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) dipped more than 11% on Wednesday after the company released results for its fourth quarter.
Williams-Sonoma reported quarterly earnings of $3.28 per share which beat the analyst consensus estimate of $2.93 per share. The company reported quarterly sales of $2.46 billion which beat the analyst consensus estimate of $2.35 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Leishen Energy Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSE#NASDAQ">LSE</a>) shares shot up 90% to $14.34 after jumping over 46% on Tuesday. The company recently reported FY24 financial results.</li>
<li>Shares of Aterian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>)got a boost, surging 54% to $3.25 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>TEN Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) shares were also up, gaining 44% to $0.8440. TEN Holdings shares jumped 18% on Tuesday after the company announced a $1 million stock repurchase program.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Wellchange Holdings Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCT#NASDAQ">WCT</a>) shares dropped 41% to $0.2347.</li>
<li>Shares of Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) were down 23% to $0.3112 after the company announced a 1-for-12 reverse stock split.</li>
<li>FST Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBSX#NASDAQ">KBSX</a>) was down, falling 21% to $4.31 after gaining 310% on Tuesday.</li>
</ul>
Commodities In commodity news, oil traded down 0.1% to $66.83 while gold traded down 0.1% at $3,037.30.
Silver traded down 1.5% to $34.290 on Wednesday, while copper rose 1.1% to $5.0695.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.2%, Germany's DAX 40 fell 0.8% and France's CAC 40 gained 0.3%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 fell 0.2%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.25%, China's Shanghai Composite Index falling 0.1%, Hong Kong's Hang Seng Index gaining 0.12% and India's BSE Sensex gaining 0.20%.
Economics
U.S. mortgage applications declined by 6.2% in the second week of March, following a cumulative 37% increase from the two prior weeks.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks">Jim Cramer Says TJX Is &#8216;Terrific,&#8217; Recommends Buying These Stocks</a></li>
</ul>

KBSX

XHLD

Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results

WIIM

Organovo shares are trading lower after the company  announced a 1-for-12 reverse stock split.

Stock Split

Organovo Announces 1-for-12 Reverse Stock Split, Effective Mar. 20

Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) today announced it has issued additional shares in conjunction with warrant exercises by investors and at-the-market stock sales. An additional 2,967,144 shares of common stock of the Company have been issued. The shares of common stock issuable upon exercise of the outstanding warrants were registered pursuant to a registration statements that was declared effective on May 8, 2024. The aggregate gross proceeds from the exercise of the existing warrants and at-the-market stock sales are expected to total approximately $2.3 million, before deducting financial advisory fees and commissions. After giving effect to the issuance of these additional shares, the Company has 20,421,617 shares of outstanding common stock.

Offerings

Organovo Holdings Issues 2,967,144 Additional Shares Through Warrant Exercises and At-The-Market Stock Sales, Raising ~$2.3M In Gross Proceeds, Bringing Total Outstanding Shares to 20,421,617

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday.
The Dow traded up 0.46% to 43,661.51 while the NASDAQ fell 1.07% to 19,080.23. The S&amp;P 500 also fell, dropping, 0.29% to 5,965.92.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43909562/top-2-industrials-stocks-that-are-set-to-fly-this-quarter">Top 2 Industrials Stocks That Are Set To Fly This Quarter</a>
Leading and Lagging Sectors Consumer staples shares jumped by 1.3% on Tuesday.
In trading on Tuesday, energy shares fell by 1.3%.
Top Headline
Keurig Dr Pepper Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) shares gained around 2.5% on Tuesday following better-than-expected quarterly results.
The company reported fourth-quarter adjusted earnings per share of 58 cents, beating the street view of 57 cents. Quarterly sales of $4.07 billion (+5.2% year over year), outpaced the analyst consensus estimate of $4.02 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) shares shot up 217% to $1.19 after the company announced that Eli Lilly is set to acquire its FXR program, including FXR314.</li>
<li>Shares of Wah Fu Education Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFU#NASDAQ">WAFU</a>)got a boost, surging 84% to $3.2950 after the company announced it will integrate DeepSeek to drive AI-based education innovation and long-term growth strategies.</li>
<li>AdaptHealth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) shares were also up, gaining 24% to $10.57 after the company reported better-than-expected fourth-quarter financial results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) shares dropped 30% to $9.11 after the company reported worse-than-expected quarterly financial results.</li>
<li>Shares of Hims &amp; Hers Health, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) were down 22% to $40.02 after the company reported fourth-quarter financial results.</li>
<li>Sempra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>) was down, falling 19% to $70.52 after the company issued FY25 EPS below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 2.4% to $69.02 while gold traded down 1.3% at $2,924.50.
Silver traded down 2% to $31.95 on Tuesday, while copper rose 0.7% to $4.5470.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.15%, Germany's DAX 40 fell 0.07% and France's CAC 40 fell 0.49%. Spain's IBEX 35 Index rose 0.80%, while London's FTSE 100 rose 0.11%.
Asia Pacific Markets
Asian markets closed mostly lower on Tuesday, with Japan's Nikkei falling 1.39%, China's Shanghai Composite Index falling 0.80%, Hong Kong's Hang Seng Index dipping 1.32% and India's BSE Sensex gaining 0.20%.
Economics
<ul>
<li>The Dallas Fed&#8217;s general business activity index for Texas's service sector fell by 2.8 points to a reading of 4.6 in February.</li>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index rose by 4.5% year-over-year in December compared to 4.3% in the previous month.</li>
<li>The FHFA house prices index increased by 0.4% in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43937701/how-to-earn-500-a-month-from-lowes-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Lowe&#8217;s Stock Ahead Of Q4 Earnings</a></li>
</ul>

AHCO

BTDR

Hims & Hers Health, Inc. Class A Common Stock

HIMS

WAFU

Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday.
The Dow traded down 0.14% to 43,401.71 while the NASDAQ fell 1.46% to 19,005.00. The S&amp;P 500 also fell, dropping, 0.77% to 5,936.91.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43909562/top-2-industrials-stocks-that-are-set-to-fly-this-quarter">Top 2 Industrials Stocks That Are Set To Fly This Quarter</a>
Leading and Lagging Sectors Consumer staples shares jumped by 1.8% on Tuesday.
In trading on Tuesday, consumer discretionary shares fell by 1.9%.
Top Headline
Home Depot Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) reported better-than-expected fourth-quarter 2024 results and provided its 2025 outlook.
HD reported fourth-quarter sales growth of 14.1% year-over-year to $39.70 billion, beating the consensus estimate of $39.14 billion. Adjusted EPS was $3.13 (+9.4% year over year), beating the consensus of $3.00.
For 2025, Home Depot said it expects total sales growth of 2% year-over-year, reaching $163.98 billion, slightly below the consensus of $164.17 billion. The company projects adjusted EPS to decline by about 2%, from $15.24 to $14.94, falling short of the $15.57 consensus estimate.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) shares shot up 332% to $1.59 after the company announced that Eli Lilly is set to acquire its FXR program, including FXR314.</li>
<li>Shares of Wah Fu Education Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFU#NASDAQ">WAFU</a>)got a boost, surging 86% to $3.3241 after the company announced it will integrate DeepSeek to drive AI-based education innovation and long-term growth strategies.</li>
<li>Femto Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMTO#NASDAQ">FMTO</a>) shares were also up, gaining 66% to $5.85.</li>
</ul>
Equities Trading DOWN
<ul>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares dropped 41% to $3.99.</li>
<li>Shares of TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) were down 40% to $4.0989.</li>
<li>Connexa Sports Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) was down, falling 38% to $0.78. Connexa Sports Technologies recently announced it signed a multi-channel-network (MCN) deal to create content for TikTok in the MENA region.</li>
</ul>
Commodities In commodity news, oil traded down 2.8% to $68.74 while gold traded down 1.8% at $2,910.00.
Silver traded down 2.6% to $31.760 on Tuesday, while copper rose 0.1% to $4.5210.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.2%, Germany's DAX 40 fell 0.1% and France's CAC 40 fell 0.5%. Spain's IBEX 35 Index rose 0.8%, while London's FTSE 100 rose 0.1%.
Asia Pacific Markets
Asian markets closed mostly lower on Tuesday, with Japan's Nikkei falling 1.39%, China's Shanghai Composite Index falling 0.80%, Hong Kong's Hang Seng Index dipping 1.32% and India's BSE Sensex gaining 0.20%.
Economics
<ul>
<li>The Dallas Fed&#8217;s general business activity index for Texas's service sector fell by 2.8 points to a reading of 4.6 in February.</li>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index rose by 4.5% year-over-year in December compared to 4.3% in the previous month.</li>
<li>The FHFA house prices index increased by 0.4% in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43937701/how-to-earn-500-a-month-from-lowes-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Lowe&#8217;s Stock Ahead Of Q4 Earnings</a></li>
</ul>

FMTO

RNAZ

SXTC

Connexa Sports Technologies Inc. - Common Stock

YYAI

Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast

Organovo Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) shares are trading higher by 198.1% to $1.12 Tuesday morning after the company announced that Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) is set to acquire its <a href="https://www.benzinga.com/pressreleases/25/02/g43938381/organovos-fxr-program-including-fxr314-to-be-acquired-by-eli-lilly-and-company">FXR program</a>, including FXR314.
What To Know: San Diego-based biotechnology company Organovo announced that Eli Lilly will acquire its FXR program, including lead asset FXR314, aimed at treating inflammatory bowel disease. Organovo Executive Chairman Keith Murphy called the deal a major milestone, highlighting Lilly's expertise in drug development.
The agreement includes an upfront payment to Organovo, along with potential milestone payments tied to regulatory and commercial achievements. Lilly will gain full commercial and intellectual property rights to the FXR program for global development. 
Read Also: <a href="https://www.benzinga.com/news/earnings/25/02/43937535/home-depot-lifts-annual-dividend-after-strong-q4-but-soft-2025-outlook-weighs-on-stock">Home Depot Lifts Annual Dividend After Strong Q4, But Soft 2025 Outlook Weighs On Stock</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ONVO has a 52-week high of $1.74 and a 52-week low of $0.32.

Why Organovo (ONVO) Stock Is Skyrocketing

Organovo Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Up 214.4%

Organovo shares are trading higher after the company announced that Eli Lilly is set to acquire its FXR program, including FXR314.

Lilly To Acquire Organovo's FXR Program, Including FXR314; Terms Not Disclosed

Management

Organovo Appoints Norman Staskey As CFO

Press Releases

Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting

Organovo Announces Appointment of Norman Staskey as Chief Financial Officer

Health Care

Contracts

Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company

Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum

Organovo Announces the Issuance of Additional Shares  in Conjunction with Warrant Exercises

Comments

Organovo Holdings

ニュース

パートナーシップ

ベンジンガ・グローバル